MIT Enterprise Forum Innovation Series Event: Pushing the Limits of Lifespan, from Innovation to Commercialization

MIT Enterprise Forum Innovation Series Event: Pushing the Limits of Lifespan, from Innovation to Commercialization

Cambridge, MA
Speaking Engagement
Life extending technologies and research are evolving exponentially, from induced pluripotent stem cells (IPS), pharmacogenomics and embedded technologies to naturally derived alternative therapies and holistic approaches. In this climate, investors and consumers are left to perform high-stakes due diligence that can influence both the financial success of a company and also one’s individual health.

This event brings together both internationally renowned researchers and leading life science investors for a conversation that explores the fascinating field of life extension, its potential for monetization and role in challenging humanity’s greatest adversary, mortality itself.

Read More About the Event

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.